About HotSpot Therapeutics
HotSpot Therapeutics is a Healthcare company based in Boston (United States) founded in 2017. Developer of a platform for protein function analysis. HotSpot Therapeutics has raised $210 million across 3 funding rounds from investors including Atlas Venture, Revelation Partners and Life Sciences Partners. The company has 37 employees. HotSpot Therapeutics offers products and services including Smart Allosteryâ„¢ Platform. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is HOTSPOT THERAPEUTICS INC. Its competitors include Insitro, Certara and GRO Biosciences; 2 of its 3 listed competitors have raised funding.
Company details
HotSpot Therapeutics offers a proprietary platform for protein structure-function analysis. The company has developed the proprietary technology platform used to analyze the allosteric druggable sites on the regulatory proteins required for its function using novel compounds.
- Headquarters Boston, United States
- Employees 37
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website hotspotthera.com
- Social LinkedIn X
- Legal Name Hotspot Therapeutics Inc
- Total Equity Funding$210M (USD)
in 3 rounds
- Latest Funding Round$100M (USD), Series C
Nov 2021
- InvestorsAtlas Venture
& 13 more
- Employee Count37
Products & Services of HotSpot Therapeutics
HotSpot Therapeutics offers a comprehensive portfolio of products and services, including Smart Allostery™ Platform.
Integrates AI, pharmacology, and chemistry for allosteric medicine development.
Funding Insights of HotSpot Therapeutics
HotSpot Therapeutics has successfully raised a total of $210M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $100 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $210M
- Total Rounds 3
- Last Round Series C — $100M
- First Round $45M
(Jul 2018)
- Investors Count 14
All 3 funding rounds of HotSpot Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | $100M | Series C | – | Pivotal bioVenture Partners | |
| May 2020 | $65M | Series B | – | SR One | |
| Jul 2018 | $45M | Series A | – | Atlas Venture, Sofinnova Partners | – |
14 investors in total: 14 institutional.
Investors in HotSpot Therapeutics
HotSpot Therapeutics has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include Atlas Venture, Revelation Partners and Life Sciences Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in life science and biotechnology sectors | 1980 | atlasventure.com | Cambridge, United States | |
Sofinnova Partners is focused on life sciences and healthcare investments. | sofinnovapartners.com | Paris, France | ||
Private equity investments in life sciences businesses are managed. | 1998 | lspvc.com | Amsterdam, Netherlands | |
A biotechnology venture capital firm investing in innovative science. | srone.com | |||
Growth-stage companies are invested in by this venture capital fund. | pavilioncapital.com | New York, United States | ||
Multistage investments are directed toward technology, healthcare, and climate sectors. | b.capital | Manhattan Beach, United States | ||
Seed and early-stage therapeutics companies are invested in by MRLV. | mrlv.com | Cambridge, United States | ||
Venture capital firm focused on healthcare startups | solasta-ventures.com | Boston, United States | ||
Brace Pharma Capital is focused on investing in innovative therapies. | bracepharma.com | Atlanta, United States | ||
Diversified investment management services are provided to clients. | 2011 | monasheecap.com | Boston, United States |
Investor details for HotSpot Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of HotSpot Therapeutics
51 people are tracked at HotSpot Therapeutics (16 in leadership, 25 in board & advisors, 10 in team); the tracked headcount is 37.
| Name | Role | Group |
|---|---|---|
Dr. Stephan Hegge | Vice President Corporate Strategy | Leadership |
Jonathan Montagu | Co-Founder & CEO | Leadership |
Nisha Perez | Head Of DMPK And Clinical Pharmacology | Leadership |
Eva Jack | COO | Leadership |
Geraldine Harriman | Co-Founder & CSO | Leadership |
Natalie Wildenradt | Senior Director, Investor Relations, Public Relations & Corporate Development | Leadership |
Joe Wahle | Svp, Head Of Immunology | Leadership |
Taeg Kim | Director, Immunology | Leadership |
Wei Liu | Vp, Data Science And Platform Biology | Leadership |
Nuruddeen Lewis | Senior Director, Immunology | Leadership |
Brian Hamman | Executive Director, Chemical Biology | Leadership |
Emma W. | Vice President, CMC And Quality Assurance | Leadership |
Fang Wang | Senior Vice President | Leadership |
Kimberly Robell | Director, Translational Sciences | Leadership |
Evan Friedman | Vice President, Development Operations | Leadership |
Yi Yao | Senior Director | Leadership |
Dan Grau | Advisor | Board & advisors |
Nicholas Keen | Advisor | Board & advisors |
Kevin Koch | Advisor | Board & advisors |
Jo Viney | Advisor | Board & advisors |
31 more people are available in the full profile.
Complete people profiles for HotSpot Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of HotSpot Therapeutics
3 dated milestones of HotSpot Therapeutics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded HotSpot Therapeutics is founded.
- Funding First funding round of $45.0M.
- Funding Latest funding round, Series C, of $100.0M.
Competitors of HotSpot Therapeutics
HotSpot Therapeutics has 3 listed competitors in our database, 2 of them funded. They include Insitro, Certara and GRO Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insitro.com | 2018 | San Francisco, United States | $643.21M | 257 | An AI-enabled platform is developed for infectious disease treatment. | |
| certara.com | 2008 | Princeton, United States | 827 | Provider of a platform for in silico drug discovery and consulting services | ||
| grobio.com | 2016 | Boston, United States | $91.15M | 22 | Synthetic biology tools are developed via genetic code recoding techniques. |
Detailed competitors of HotSpot Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of HotSpot Therapeutics
The website of HotSpot Therapeutics (hotspotthera.com) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 15.6% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as HotSpot Therapeutics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hotspot Therapeutics
Complete news archive for HotSpot Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HotSpot Therapeutics
HotSpot Therapeutics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
HotSpot Therapeutics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
HotSpot Therapeutics is a funded company, having raised a total of $210M across 3 funding rounds to date. The company's 1st funding round was a Series A of $45M, raised on Jul 2018.
HotSpot Therapeutics has 37 employees.
HotSpot Therapeutics offers a proprietary platform for protein structure-function analysis. The company has developed the proprietary technology platform used to analyze the allosteric druggable sites on the regulatory proteins required for its function using novel compounds.
HotSpot Therapeutics's top competitors include Insitro, Certara and GRO Biosciences.
HotSpot Therapeutics offers Smart Allosteryâ„¢ Platform.
HotSpot Therapeutics has 14 investors. Key investors include Atlas Venture, Revelation Partners, Life Sciences Partners, Tekla Capital Management, and Monashee Investment Management.
HotSpot Therapeutics operates through Hotspot Therapeutics Inc.